SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Avenue Therapeutics, Inc. – ‘CORRESP’ from 10/24/23

On:  Tuesday, 10/24/23, at 5:11pm ET   ·   Delayed-Release:  Filing  –  Release Delayed   ·   Accession #:  1104659-23-111134

Previous ‘CORRESP’:  ‘CORRESP’ on 10/24/23   ·   Next:  ‘CORRESP’ on 10/27/23   ·   Latest:  ‘CORRESP’ on 1/30/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/24/23  Avenue Therapeutics, Inc.         CORRESP11/30/23    1:7K                                     Toppan Merrill/FA

Comment-Response or Other Letter to the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: CORRESP     Comment-Response or Other Letter to the SEC         HTML      7K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



October 24, 2023

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-1004

 

  Re: Avenue Therapeutics, Inc.
    Registration Statement on Form S-1, as amended
    File No. 333-274562

 

Ladies and Gentlemen:

 

As the placement agent of the proposed offering of Avenue Therapeutics, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:30 p.m., Eastern Time, on Wednesday, October 25, 2023, or as soon thereafter as is practicable, or at such other time as may be advised by the Company’s counsel.

 

Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through October 24, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 23, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

 

  Very truly yours,  
     
  Maxim Group LLC  
     
  By:  /s/ Clifford A. Teller  
    Name: Clifford A. Teller
Title: Co-President
 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘CORRESP’ Filing    Date    Other Filings
10/25/23
Filed on:10/24/23CORRESP,  S-1/A
10/23/23S-1/A
 List all Filings 
Top
Filing Submission 0001104659-23-111134   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 6:35:45.1pm ET